EGI.L Regulatory News (EGI)

Electrical Geodesics, Inc.

EGI Expands Clinical Product Line

through Distribution Agreement with EB Neuro

EUGENE, OREGON, US, 22 April 2015 - Electrical Geodesics, Inc. ("EGI" or the "Company"), a leading neurodiagnostic medical technology company, today announces it has entered into an agreement to distribute a range of EEG products manufactured by EB Neuro S.p.A. ("EB Neuro") in the US market. Sold under the EGI name, the products will expand the Company's US product line to include long term monitoring and ambulatory EEG, and electromyography/evoked potential ("EMG/EP") products, providing a broader portfolio of related neurology monitoring products for the clinical market.

EB Neuro, based in Northern Italy, develops, markets and distributes a wide range of medical devices. This agreement supplements existing collaborations between the two companies, with EB Neuro manufacturing the GEM low channel count ambulatory EEG device sold by EGI and serving as EGI's distributor in Italy.

EB Neuro's NeMus, NeMus 2, BE Micro and BE Plus LTM products are well established and sold worldwide and are CE marked and 510(k) cleared. They offer a practical and cost-effective solution for routine clinical and research use. The devices operate with EB Neuro's proprietary Galileo operating software, a Windows-based system that has recently been cleared for sale for clinical use in the US.

Don Tucker, CEO of EGI, commented: "Having worked with EB Neuro for many years, we admire the innovation they deliver and their manufacturing capabilities. Their devices and software are a perfect adjunct and complement to our GES 400 devices. Whilst our GES 400 high-density EEG systems target the more advanced clinical uses and translational research in clinics and hospitals, the EB Neuro products expand our offering for the more routine needs of clinical customers."

Ing. Marco Rossi, Managing Director of EB Neuro, commented: "Our Galileo software platform has recently received FDA 510(k) clearance and is a multidisciplinary platform which allows the use of all EB Neuro's systems for neurological applications including EEG, EMG, EP and others. With its HL7 Protocol compatibility, Galileo is a highly compelling solution for hospital network integrations both in small clinics and in large hospital departments. EGI has a strong reputation and presence and we believe this alliance will deliver great benefits to both businesses in the important US clinical market."

For more information contact:

Notes to Editors

Electrical Geodesics, Inc. in Summary

Founded in 1992, EGI designs, develops and commercialises a range of non-invasive neurodiagnostic and neuromodulation products used to monitor, interpret and modulate brain activity, based on its proprietary dense array electroencephalography ("dEEG") platform technology. The Company's technology uses up to 256 sensors, providing much higher resolution brain activity data compared to conventional 8 or 16 channel EEG and is used in medical, clinical and research settings in a diverse range of applications including important areas such as the diagnosis and monitoring of epilepsy, neurosurgical planning, sleep assessment, and many others.

EGI's dEEG systems, available in the GES 300 and now the GES 400 lines, capitalise on the Company's unique Geodesic Sensor Net which allows faster, easier, and more convenient placement of many EEG sensors in an even distribution over the entire scalp, providing more accurate and precise diagnosis and measurement. EGI's technology is now widely used in neuroscience research laboratories and is becoming more commonly used in clinics, care centers, and hospitals around the world. Data is measured and visualised using EGI's proprietary amplifier technology and software, providing a complete, advanced, high-resolution EEG platform. The Company's products are compatible with multiple diagnostic and imaging technologies, including magnetic resonance (MR) imaging, functional MRI (fMRI), and magneto-encephalography (MEG).

See our website www.egi.com

EB Neuro S.p.A.

EBNeuro, based in Verona and Florence, is a company devoted to the design, manufacture, worldwide supply and support of diagnostic, therapeutic and clinical research products and services. The range of products covers various fields, and includes units for neurology, including electroencephalography, electromyography and evoked potentials, ambulatory recordings, polisomnography and sleep analysis, video EEG and TMS. The Company also supplies devices for use in cardiology and uro-gastroenterology, including manometry and ECG devices.

EBNeuro is ISO 9001 and ISO 13485 certified and a number of the products CE marked and FDA 510(k) cleared.

Glossary

.